About
Basic Data Updated:
9 days agoThe Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 95.00 cr and a paid-up capital of Rs 81.93 cr.
The Corporate currently has active open charges totaling ₹1.50 cr. It has already closed loans amounting to ₹2.10 cr, as per the Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Alphamed Formulations Private Limited India is Sudheer Gundu as Company Secretary. Lorraine Hill, Chris Botha, and Ramesh Cheruvu serve as directors at the Company.
Industry
Company Details
- Location
Shamirpet, Telangana, India
- Website12224421
- Telephone12224421
- Email Address12224421
- Social Media12224421
| CIN/LLPIN/FCRN | U24239TG2006PTC051732 |
| Company No. | 051732 |
| Company Classification | Private Limited Indian Non-Government Company |
| Incorporation Date | 20 Nov 2006 |
| Date of AGM | 27 Sep 2023 |
| Date of Balance Sheet | 31 Mar 2023 |
| Listing Status | Unlisted |
| ROC Code | Roc Hyderabad |
Products or Services related to Alphamed Formulations Private Limited
Olopatadine HCL
Timolol Maleate Solution
Financials of Alphamed Formulations Private Limited
Alphamed Formulations Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 15.87% increase. The company also saw a substantial fall in profitability, with a 88.95% decrease in profit. The company's net worth Soared by an impressive increase of 29.33%.
Corporate Structure
Unlock access to Alphamed Formulations's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Alphamed Formulations Private Limited
Unlock and access historical data on people associated with Alphamed Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Executive Team (1)
SG
Sudheer Gundu
Company SecretaryAppointment Date: 13-Jun-2019
Status: Current
Board Members(3)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 29 Sep 2023 | ₹1.50 Cr | Open |
State Bank Of India Creation Date: 27 Aug 2008 | ₹0.95 M | Satisfied |
State Bank Of India Creation Date: 24 Aug 2007 | ₹2.00 Cr | Satisfied |
Deals i
Gain comprehensive insights into the Deals and Valuation data of Alphamed Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alphamed Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Recent activity within the organization
Charges
A charge registered on 24 Aug 2007 via Charge ID 10065860 with State Bank Of India was fully satisfied on 05 Oct 2023.
05 Oct 2023Charges
A charge with State Bank Of India amounted to Rs. 1.50 cr with Charge ID 100795318 was registered on 29 Sep 2023.
29 Sep 2023Annual General Meeting
Alphamed Formulations Private Limited last Annual general meeting of members was held on 27 Sep 2023 as per latest MCA records.
27 Sep 2023Balance Sheet
Alphamed Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad.
31 Mar 2023Charges
A charge with State Bank Of India of Rs. 2.00 cr registered on 24 Aug 2007 with Charge ID 10065860 was modified on 16 Apr 2021.
16 Apr 2021
Recent News, Updates & Announcement
Laurus Labs Acquires Phekolong Pharmaceuticals for ZAR 75000 Expands Reach in South African ARV Market.Laurus Labs buys Phekolong Pharmaceuticals for ZAR 75000 Deal to be done by November Laurus gets access to South African ARV market while Aspen will still make ARVs for public sector Laurus also makes APIs for cancer and other diseases.
Business Medical Dialogues 24 Sep 2019
- Aspen Strikes Deal With Indias Laurus to Cut Cost of HIV Drugs.
Aspen plans to license intellectual property rights owned by Laurus.
NDTV Profit 20 Sep 2019
- Warburg Pincusbacked Laurus Labs buys South African firm.
VCCircle 18 Sep 2019
- Singapores Temasek to sell Intouch stake for nearly THB 16 bln.
Telecompaper 16 Aug 2019
Frequently asked questions
What is the Incorporation or founding date of Alphamed Formulations Private Limited?
